Kezar Life Sciences, Inc.
SEC CIK 1645666 · KZR · last insider filing 2026-05-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Berger Franklin M | Director | filed 2018 - 2026 |
| Kauffman Michael | Director | filed 2018 - 2026 |
| Cooper Graham K | Director | filed 2018 - 2026 |
| Garner Elizabeth | Director | filed 2019 - 2026 |
| Kirk Christopher J. | Director · President and CSO | filed 2018 - 2026 |
| Fowler John Franklin | Director · CEO | filed 2018 - 2026 |
| Wallace Courtney | Director | filed 2021 - 2026 |
| Klearman Micki | Director | filed 2021 - 2026 |
| Sommadossi Jean-Pierre | Director | filed 2018 - 2021 |
| Dinges Jason | Director | filed 2018 - 2021 |
| Chen Bihua | Director | filed 2018 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Belsky Marc | Chief Financial Officer | filed 2018 - 2026 |
| Schiller Mark C. | Chief Operating Officer | filed 2024 - 2026 |
| Chiang Pichi Luo | SVP, Corporate Controller | filed 2025 - 2026 |
| To Zung Phuong | SVP, Clinical Development | filed 2025 - 2025 |
| Mordwinkin Nicholas Michael | Chief Business Officer | filed 2022 - 2024 |
| Henig Noreen | Chief Medical Officer | filed 2020 - 2023 |
| Economides Vassiliki | SVP, Strategy & External Aff. | filed 2019 - 2021 |
| Goel Niti | Chief Medical Officer | filed 2018 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.